that could be performed rapidly and accurately, while requiring very small amounts of blood, all using compact automated devices that the company had developed. These claims were proven to be false.

A turning point came in 2015, when medical research professor John Ioannidis, and later professor of clinical biochemistry Eleftherios Diamandis, along with investigative journalist John Carreyrou of The Wall Street Journal,